http://dx.doi.org/10.1016/j.stem.2014.04.014
The more interesting part of this to my eyes was the material difference between 24 hour and 72 hour fasting in human chemotherapy patients, in that the former didn't do anything to the measure of immune cell populations and the latter did. Intermittent fasting is nowhere near as well studied as calorie restriction at this point in time, so it is interesting to see these mechanisms emerge.
Now this is chemotherapy immune suppression, not aging immune dysregulation. I'll be mildly surprised to see the exact same result in people with age-damaged immune systems, as the character of the damage is very different. The animal results for aging rather than chemotherapy here are intriguing but that's all. There's still a lot of work to be done to arrive at the level of comfort with this effect that exists for other aspects of calorie restriction or intermittent fasting.
But given that (a) obtaining human data on fasting and immune cell population in old people is a comparatively low cost study to put together, and (b) the group involved here seems to have a good flow of funding to study intermittent fasting in a broader context, I'd expect to see that data emerge at some point in the next few years.